Appendix 4E and Annual Report
Released
Released
Announcement PDF
HITIQ Limited
Cover page
30 June 2026
HITIQ Limited
Appendix 4E
Preliminary final report
1. Company details
Name of entity: HITIQ Limited
ABN: 53 609 543 213
Reporting period: For the year ended 30 June 2026
Previous period: For the year ended 30 June 2025
2. Results for announcement to the market
$
Revenues from ordinary activities down 21.0% to 1,592,466
Loss from ordinary activities after tax attributable to the owners of HITIQ
Limited down 15.4% to (6,101,158)
Loss for the year attributable to the owners of HITIQ Limited down 15.4% to (6,101,158)
Dividends
There were no dividends paid, recommended or declared during the current financial period.
Comments
The loss for the consolidated entity after providing for income tax amounted to $6,101,158 (30 June 2025: $7,212,305).
3. Control gained over entities
Not applicable.
4. Loss of control over entities
Not applicable.
5. Dividends
Current period
There were no dividends paid, recommended or declared during the current financial period.
Previous period
There were no dividends paid, recommended or declared during the previous financial period.
6. Details of associates and joint venture entities
Not applicable.
7. Audit qualification or review
Details of audit/review dispute or qualification (if any):
The financial statements have been audited and an unmodified opinion has been issued.
HITIQ Limited
Appendix 4E
Preliminary final report
8. Attachments
Details of attachments (if any):
The Annual Report of HITIQ Limited for the year ended 30 June 2026 is attached.
9. Signed
Signed ___________________________ Date: 28 August 2026
HITIQ Limited
ABN 53 609 543 213
Annual Report - 30 June 2026
HITIQ Limited
Letter from the Board
30 June 2026
1
Letter from the Board
Dear Fellow Shareholders,
On behalf of the Board, we are pleased to present HITIQ Limited's 2026 Annual Report.
Y26 was a defining year in HITIQ's evolution. We accelerated the commercialisation of our concussion management
platform and broadened the Company's presence across retail, research, defence and insurance markets. Building on years
of product development and validation, HITIQ continued the rollout of PROTEQT™ while extending our technology into
new institutional and consumer channels.
The Company reached several important milestones during the year as HITIQ continued its transition from product
development into commercial deployment and institutional validation. A key highlight was the Company's work with the
Australian Sports Commission through The Park program, where HITIQ's instrumented mouthguard technology was used
in a blinded pilot project across Australian combat sports to compare objective head impact data with athlete-reported
perceptions. The program reinforced the role of objective data in athlete brain health and demonstrated HITIQ's ability to
support leading sporting bodies with practical, evidence-based monitoring tools.
Alongside the national retail rollout of PROTEQT™ through Rebel and the development of strategic relationships across
insurance, research and sport, these initiatives strengthened the foundations for broader adoption of HITIQ's technology.
Commercial momentum built through the year, marked by the start of national retail distribution through Rebel and the
development of strategic relationships across universities, research institutions, defence and insurance markets. We also
entered a world-first partnership with Sportscover to integrate PROTEQT™ data into sports insurance underwriting and
claims — the first time head impact monitoring has been built directly into an insurance product, creating a new
commercial channel for the Company's technology.
Scientific validation remained central to our strategy. PROTEQT™ was selected for inclusion in major research programs,
including an Australian Research Council-funded initiative, while ongoing collaborations with universities, sporting
organisations and researchers continued to expand the evidence base supporting our platform. These partnerships are
critical to building trust in objective concussion management and position HITIQ at the forefront of innovation in brain
health, athlete monitoring and injury risk assessment.
FY26 was also a period of investment in the Company's future capabilities. HITIQ secured support through the Victorian
Government's advanced manufacturing and research programs, expanded its engineering and manufacturing capability in
Victoria, and continued to build out its data, analytics and product ecosystem — laying the operational groundwork
needed to scale.
The Board is mindful that FY26 was not without its challenges, including regulatory timelines in international markets and
the funding demands of scaling manufacturing and commercial operations. During the year, the Company took a number
of steps to strengthen its balance sheet and maintain the funding capacity needed to support delivery against its
commercial pipeline. We are encouraged by the progress made, while recognising there is more work ahead to translate
that progress into sustained commercial success.
We also welcomed important additions to the Board and leadership team this year. The appointment of Tony Toohey as a
Non-Executive Director, alongside the ongoing leadership of Executive Chair Earl Eddings and our experienced
management team, has added to the Company's governance, commercial expertise and strategic direction.
Looking ahead to FY27, the Board believes HITIQ is well placed to build on the opportunities emerging across defence,
universities, insurance and retail markets. Our focus remains on converting validation into long-term commercial
outcomes, growing recurring revenue, and continuing to build a global platform that improves athlete safety.
2
HITIQ Limited
Letter from the Board
30 June 2026
On behalf of the Board, we thank our shareholders for their continued support and confidence, and acknowledge the
dedication of our employees, partners and customers, whose commitment to our mission continues to drive HITIQ
forward.
Earl Eddings
Executive Chair, on behalf of the Board
HITIQ Limited
Corporate directory
30 June 2026
3
Directors Earl Eddings
Philip Carulli - ResignedSyntax Warning: Bad annotation destination
31 October 2025
Matthew Clayworth
Jennifer Tucker - Resigned 27 July 2026
Tony Toohey - Appointed 31 October 2025
James Barrie - Resigned 31 January 2026
Company secretaries James Barrie - Resigned 31 January 2026
Michelle Sabatino - Resigned 10 February 2026
Lachlan Mallia - Appointed 10 February 2026
Nova Taylor - Appointed 10 February 2026
Registered office Unit 4
38-42 White Street
South Melbourne, VIC, 3205
Phone: 0478 038 567
Principal place of business Unit 4
38-42 White Street
South Melbourne, VIC, 3205
Phone: 0478 038 567
Share register Automic Group
Level 2, 267 St Georges Terrace
Perth, WA, 6000
Phone: 1300 288 664
Auditor William Buck
Level 20, 181 William Street
Melbourne VIC 3000
Bankers Commonwealth Bank of Australia
3 Queen Street
Fremantle, WA, 6161
Stock exchange listing Australian Securities Exchange
Level 40, Central Park,
152 - 158 St George's Terrace, Perth WA 6000
Listing code Ordinary shares - HIQ
Website www.hitiq.com
HITIQ Limited
Contents
30 June 2026
4
Directors' report 5
Auditor's independence declaration 17
Statement of profit or loss and other comprehensive income 18
Statement of financial position 19
Statement of changes in equity 20
Statement of cash flows 21
Notes to the financial statements 22
Consolidated entity disclosure statement 38
Directors' declaration 39
Independent auditor's report to the members of HITIQ Limited 40
Shareholder information 44
General information
The financial statements cover HITIQ Limited as a consolidated entity consisting of HITIQ Limited and the entities it controlled
at the end of, or during, the year. The financial statements are presented in Australian dollars, which is HITIQ Limited's
functional and presentation currency.
HITIQ Limited is a listed public company limited by shares, incorporated and domiciled in Australia. Its registered office and
principal place of business are:
Registered office Principal place of business
Unit 4 Unit 4
38-42 White Street 38-42 White Street
South Melbourne, VIC, 3205 South Melbourne, VIC, 3205
Phone: 0478 038 567 Phone: 0478 038 567
A description of the nature of the consolidated entity's operations and its principal activities are included in the directors' report,
which is not part of the financial statements.
The financial statements were authorised for issue, in accordance with a resolution of directors, on 28 August 2026. The
directors have the power to amend and reissue the financial statements.
HITIQ Limited
Directors' report
30 June 2026
5
The directors present their report, together with the financial statements, on the consolidated entity (referred to hereafter as
the 'consolidated entity') consisting of HITIQ Limited (referred to hereafter as the 'company' or 'parent entity') and the entities
it controlled at the end of, or during, the year ended 30 June 2026.
Directors
The following persons were directors of HITIQ Limited during the whole of the financial year and up to the date of this report,
unless otherwise stated:
Earl Eddings - Executive Chairman
Philip Carulli - Resigned 31 October 2025
Matthew Clayworth
Jennifer Tucker - Resigned 27 July 2026
Tony Toohey - Appointed 31 October 2025
James Barrie - Resigned 31 January 2026
Principal activities
During the financial year the principal continuing activities of the consolidated entity were the development and
commercialisation of concussion management technology.
No significant change in the nature of these activities occurred during the year.
HITIQ Limited
Directors' report
30 June 2026
6
Key risks and uncertainties
HITIQ Limited is subject to both specific and general business risks. The key risks and uncertainties that may impact the
Group include:
Sufficiency of funding
The Group requires sufficient funding to continue its operations, support the commercialisation of its products and technology
and achieve its longer-term objectives. The Group's ability to meet its obligations is dependent on achieving forecast revenues,
managing expenditure, receiving expected government grants and R&D-related funding and, where required, securing
additional funding.
Commercialisation and market adoption
The Group's future performance is dependent on successfully commercialising its products and technology. There is a risk
that customer adoption, sales volumes, commercial contracts or entry into new markets may take longer than anticipated or
not achieve the levels forecast. This may impact revenue, cash flow and future funding requirements.
Technology, manufacturing and product quality risk
The Group's technology and products must operate reliably and meet required quality and performance standards. Product
or technology failures, manufacturing issues, delays in development or quality problems could result in additional costs, delays
in commercialisation and damage to the Group's reputation.
Supplier and supply chain risk
The Group relies on external suppliers and manufacturers for a number of key components and services. There is no
guarantee that these suppliers will be able to meet the Group's requirements for quality, cost, timing, volume or regulatory
compliance. Supply interruptions or increases in costs could adversely impact the Group's operations and ability to supply
customers.
Regulatory and compliance risk
Certain HITIQ products and markets are subject to regulatory, medical device and other compliance requirements. Changes
to regulatory requirements, delays in obtaining required approvals or additional compliance requirements may increase costs
or delay the commercialisation of products in particular markets.
Protection of intellectual property
The Group's ability to protect its intellectual property, including patents, designs, software, technology and know-how, is
important to its competitive position. There is a risk that intellectual property may not be adequately protected, may be
challenged by third parties or that the Group may incur significant costs in protecting or enforcing its intellectual property rights.
Competition and development of competing technology
The markets in which the Group operates are competitive and continue to develop. Existing or new competitors may develop
similar or superior products and technologies, compete more aggressively on price or marketing, or bring products to market
more quickly. This could impact the Group's market position, sales and profitability.
Key customers and commercial relationships
The Group's commercialisation strategy includes relationships with sporting organisations, retailers, research institutions,
defence organisations and other commercial partners. Delays, changes or termination of material relationships or contracts
may adversely affect forecast revenue and the timing of the Group's growth plans.
Dividends
There were no dividends paid, recommended or declared during the current or previous financial year.
Review of operations
The loss for the consolidated entity after providing for income tax amounted to $6,101,158 (30 June 2025: $7,212,305).
HITIQ Limited
Directors' report
30 June 2026
7
Significant changes in the state of affairs
In August 2025, 12,407,275 ordinary shares were issued at $0.022 each as part of a placement under a shortfall offer as part
of a pro-rata non-renounceable rights issue offer announced to the market in May 2025. This resulted in a cash inflow for the
Company of $272,960.
On 2 October 2025, 11,363,637 ordinary shares were issued at $0.022 each following completion of the Company's $250,000
placement. Every two shares entitled investors to one option resulting in 5,681,819 options being exercisable at $0.022 and
expiring on 30 December 2028.
On 16 December 2025, 40,909,092 ordinary shares were issued at $0.022 each following completion of the Company's
$900,000 placement. Every two shares entitled investors to one option resulting in 20,454,544 options being exercisable at
$0.022 and expiring on 30 December 2028.
During the year, 6,425,631 ordinary shares were issued in lieu of services provided to the company, and 1,780,000 ordinary
shares were issued upon the exercise of performance rights.
During the year, 220,862,993 ordinary shares were issued upon conversion of convertible notes to equity.
There were no other significant changes in the state of affairs of the consolidated entity during the financial year.
Matters subsequent to the end of the financial year
Subsequent to the end of the reporting period, the following significant events took place:
- In July 2026, the consolidated entity completed the first tranche of its placement resulting in a cash inflow of $1.2m with the
second tranche of $0.2m expected to be received following the EGM on 7 September.
- On 27 July 2026, Jennifer Tucker resigned as a Non-Executive Director of the company.
- On 29 July 2026, the consolidated entity received the first tranche of $480,000 of its grant from InvestVic.
- On 27 August 2026, Harmil exercised its right under the convertible note facility to convert $1 million of outstanding
convertible notes into ordinary shares. As the conversion occurred after the reporting date, no adjustment has been made to
the amounts recognised in these financial statements.
No other matter or circumstance has arisen since 30 June 2026 that has significantly affected, or may significantly affect the
consolidated entity's operations, the results of those operations, or the consolidated entity's state of affairs in future financial
years.
Likely developments and expected results of operations
Information on likely developments in the operations of the consolidated entity and the expected results of operations have
not been included in this report because the directors believe it would be likely to result in unreasonable prejudice to the
consolidated entity.
Information on directors
The following information is current as at the date of this report.
Name: Earl Eddings
Title: Executive Chair
Experience and expertise: Earl Eddings brings extensive experience in sports governance and business
leadership, having served as chair of Cricket Australia and a Director of the International
Cricket Council. His strategic acumen and deep industry connections are instrumental
in positioning HITIQ for global growth.
Other current directorships: N/A
Former directorships (last 3 years): N/A
Interests in shares: 16,414,667
Interests in options: 938,701
Interests in rights: 5,250,000
HITIQ Limited
Directors' report
30 June 2026
8
Name: Matthew Clayworth
Title: Non-Executive Director
Experience and expertise: Mr Clayworth is a Director of Wealth Management with Canaccord Genuity with over 20
years' experience in financial markets. Previous roles include working for Deutsche
Bank, Citi Smith Barney and Morgan Stanley as Vice President in Private Wealth.
Matthew holds a Bachelor of Commerce from the University of Queensland and a
Graduate Diploma in Applied Finance and Investment. He is currently Director of DHD
Surf and co-founder and Director of Smart AI Connect.
Other current directorships: N/A
Former directorships (last 3 years): N/A
Interests in shares: 288,947,302
Interests in options: 928,573
Interests in rights: 477,273
Name: Tony Toohey
Title: Non-Executive Director
Experience and expertise: Mr Toohey has over 35 years' experience in the gaming, hospitality, leisure and
technology industries. He is the former MD, CEO and Executive Chairman of ASX-listed
Intecq Limited and served as GM Business Development Gaming at Tabcorp from 2016
until July 2018. Mr Toohey was also previously Executive Director and Chairman of MSL
Solutions Limited (ASX: MSL) from 2019 until its acquisition in 2023 for $123m. He
currently serves as a Director of North Sydney Leagues Club Ltd, Focus on Gaming Ltd,
Trax Technologies Pty Ltd and Thinxtra Pty Ltd.
Other current directorships: N/A
Former directorships (last 3 years): N/A
Interests in shares: 840,909
Interests in options: 340,909
Interests in rights: 477,273
'Other current directorships' quoted above are current directorships for listed entities only and excludes directorships of all
other types of entities, unless otherwise stated.
'Former directorships (last 3 years)' quoted above are directorships held in the last 3 years for listed entities only and excludes
directorships of all other types of entities, unless otherwise stated.
Company secretary
Lachlan Mallia
Mr Mallia is a Director at Bio101 Financial Advisory, a financial services firm providing outsourced CFO, taxation and company
secretarial solutions to the Healthcare sector. Mr Mallia brings extensive finance and commercial expertise, having worked
with both public and private companies across Australia for several years. He currently serves as a CFO and Company
Secretary for a number of public and private Healthcare companies. He holds a Bachelor of Business and Bachelor of Banking
and Finance from Monash University and a Certificate in Governance Practice from the Governance Institute of Australia and
is a qualified Chartered Accountant.
Nova Taylor
Ms Taylor is a professional Company Secretary with approximately 9 years' experience working with ASX listed companies
across multiple industries. Nova holds a Bachelor of Science and Bachelor of Laws from Deakin University.
HITIQ Limited
Directors' report
30 June 2026
9
Meetings of directors
The number of meetings of the company's Board of Directors ('the Board') held during the year ended 30 June 2026, and the
number of meetings attended by each director were:
Full Board
Attended Held
Philip Carulli - Resigned 31 October 2025 10 10
Matthew Clayworth 22 23
James Barrie - Resigned 31 January 2026 13 13
Earl Eddings 22 23
Jennifer Tucker - Resigned 27 July 2026 21 23
Tony Toohey - Appointed 31 October 2025 12 13
Held: represents the number of meetings held during the time the director held office.
Remuneration report (audited)
The remuneration report details the key management personnel remuneration arrangements for the consolidated entity, in
accordance with the requirements of the Corporations Act 2001 and its Regulations.
Key management personnel are those persons having authority and responsibility for planning, directing and controlling the
activities of the entity, directly or indirectly, including all directors.
The remuneration report is set out under the following main headings:
● Principles used to determine the nature and amount of remuneration
● Details of remuneration
● Service agreements
● Share-based compensation
● Additional information
● Additional disclosures relating to key management personnel
Principles used to determine the nature and amount of remuneration
The objective of the consolidated entity's executive reward framework is to ensure reward for performance is competitive and
appropriate for the results delivered. The framework aligns executive reward with the achievement of strategic objectives and
the creation of value for shareholders, and it is considered to conform to the market best practice for the delivery of reward.
The Board of Directors ('the Board') ensures that executive reward satisfies the following key criteria for good reward
governance practices:
● competitiveness and reasonableness
● acceptability to shareholders
● performance linkage / alignment of executive compensation
● transparency
The Board is responsible for determining and reviewing remuneration arrangements for its directors and executives. The
performance of the consolidated entity depends on the quality of its directors and executives. The remuneration philosophy is
to attract, motivate and retain high performance and high-quality personnel. The board has not sought the assistance of a
remuneration consultant during the year.
The reward framework is designed to align executive reward to shareholders' interests. The Board has considered that it
should seek to enhance shareholders' interests by:
● having economic profit as a core component of plan design
● focusing on sustained growth in shareholder wealth, consisting of dividends and growth in share price, and delivering
constant or increasing return on assets as well as focusing the executive on key non-financial drivers of value
● attracting and retaining high calibre executives
Additionally, the reward framework should seek to enhance executives' interests by:
● rewarding capability and experience
● reflecting competitive reward for contribution to growth in shareholder wealth
● providing a clear structure for earning rewards
HITIQ Limited
Directors' report
30 June 2026
10
In accordance with best practice corporate governance, the structure of non-executive director and executive director
remuneration is separate.
Non-executive directors' remuneration
Fees and payments to non-executive directors reflect the demands and responsibilities of their role. Non-executive directors'
fees and payments are reviewed annually by the Board. The Board may, from time to time, receive advice from independent
remuneration consultants to ensure non-executive directors' fees and payments are appropriate and in line with the market.
The chairman's fees are determined independently to the fees of other non-executive directors based on comparative roles in
the external market.
ASX listing rules require the aggregate non-executive directors' remuneration be determined periodically by a general meeting.
The remuneration of non-executive directors was set in the Company's Prospectus upon IPO, dated 22 April 2021, which set
a cap of $400,000.
Executive remuneration
The consolidated entity aims to reward executives based on their position and responsibility, with a level and mix of
remuneration which has both fixed and variable components.
The executive remuneration and reward framework has four components:
● base pay and non-monetary benefits
● short-term performance incentives
● share-based payments
● other remuneration such as superannuation and long service leave
The combination of these comprises the executive's total remuneration.
Fixed remuneration, consisting of base salary, superannuation and non-monetary benefits, is reviewed annually by the Board
based on individual and business unit performance, the overall performance of the consolidated entity and comparable market
remuneration.
Executives may receive their fixed remuneration in the form of cash or other fringe benefits (for example motor vehicle benefits)
where it does not create any additional costs to the consolidated entity and provides additional value to the executive.
The short-term incentives ('STI') program is designed to align the targets of the business units with the performance hurdles
of executives. STI payments are granted to executives based on specific annual targets and key performance indicators
('KPI's') being achieved. KPI's include profit contribution, customer satisfaction, leadership contribution and product
management.
The long-term incentives ('LTI') include long service leave and share-based payments. Shares are awarded to executives over
a period of three years based on long-term incentive measures. These include increase in shareholder value relative to the
entire market and the increase compared to the consolidated entity's direct competitors. The Board reviewed the long-term
equity-linked performance incentives specifically for executives during the year ended 30 June 2024.
Consolidated entity performance and link to remuneration
Remuneration for certain individuals is directly linked to the performance of the consolidated entity. A portion of cash bonus
and incentive payments are dependent on defined earnings per share targets being met. The remaining portion of the cash
bonus and incentive payments are at the discretion of the Board. Refer to the section '' below for details of the earnings and
total shareholder return for the last five years.
The Board is of the opinion that the continued improved results can be attributed in part to the adoption of performance based
compensation and is satisfied that this improvement will continue to increase shareholder wealth if maintained over the coming
years.
Voting and comments made at the company's 28 November 2025 Annual General Meeting ('AGM')
At the 28 November 2025 AGM, 98.67% of the votes received supported the adoption of the remuneration report for the year
ended 30 June 2025. The company did not receive any specific feedback at the AGM regarding its remuneration practices.
HITIQ Limited
Directors' report
30 June 2026
11
Details of remuneration
Amounts of remuneration
Details of the remuneration of key management personnel of the consolidated entity are set out in the following tables.
Short-term benefits
Post-
employment
benefits
Long-term
benefits
Share-
based
payments
Cash salary Cash Non- Super-
Long
service Equity-
and fees bonus monetary annuation leave settled Total
2026 $ $ $ $ $ $ $
Non-Executive Directors:
Philip Carulli * 7,000 - - - - 7,000 14,000
Matthew Clayworth 21,000 - - - - 29,114 50,114
Jennifer Tucker ** 21,000 - - - - 29,114 50,114
Tony Toohey *** - - - - - 39,614 39,614
James Barrie **** 3,500 - - - - - 3,500
Executive Directors:
Earl Eddings 290,769 - 16,873 34,892 - 61,848 404,382
343,269 - 16,873 34,892 - 166,690 561,724
During the financial year, the Non-Executive Directors received 50% of their fees in cash and the remaining 50% in equity.
Tony Toohey elected to also have his cash fees issued as equity which will be tabled for approval at the Company’s 2026
AGM.
*Resigned 31 October 2025
**Resigned 27 July 2026
***Appointed 31 October 2025
****Resigned 31 January 2026
Short-term benefits
Post-
employment
benefits
Long-term
benefits
Share-
based
payments
Cash salary Cash Non- Super-
Long
service Equity-
and fees bonus monetary annuation leave settled Total
2025 $ $ $ $ $ $ $
Non-Executive Directors:
Philip Carulli * 21,000 - - - - 21,000 42,000
Matthew Clayworth * 21,000 - - - - 21,000 42,000
James Barrie * 55,368 - - - - 21,000 76,368
Jennifer Tucker 17,500 - - - - - 17,500
Executive Directors:
Earl Eddings 199,345 - 15,740 22,925 - 111,891 349,901
314,213 - 15,740 22,925 - 174,891 527,769
*During the financial year the director received $26,250 of shares which included 50% of their remuneration for the period
from April 2024. Accordingly, $5,250 of the shares received relate to their remuneration received in the year ending 30 June
2024.
HITIQ Limited
Directors' report
30 June 2026
12
The proportion of remuneration linked to performance and the fixed proportion are as follows:
Fixed remuneration At risk - STI At risk - LTI
Name 2026 2025 2026 2025 2026 2025
Non-Executive Directors:
Philip Carulli 100% 100% - - - -
Matthew Clayworth 84% 100% - - 16% -
Jennifer Tucker 84% 100% - - 16% -
Tony Toohey 80% - - - 20% -
James Barrie 100% 100% - - - -
Executive Directors:
Earl Eddings 100% 68% - - - 32%
Service agreements
Remuneration and other terms of employment for key management personnel are formalised in service agreements. Details
of these agreements are as follows:
Name: Earl Eddings
Title: Executive Chairman
Agreement commenced: 3 October 2024
Details: Executive Chairman on a fixed remuneration of $308,000 per annum plus
superannuation. Short-Term Incentives of 50% of fixed remuneration plus market-based
performance rights as Long Term Incentives. Notice period of 3 months.
Name: Matthew Clayworth
Title: Non-Executive Director
Agreement commenced: 29 November 2023
Term of agreement: Ongoing
Details: $42,000 per annum plus GST. No leave entitlements or notice period required.
Name: Jennifer Tucker
Title: Non-Executive Director
Agreement commenced: 31 January 2025
Term of agreement: Ongoing
Details: $42,000 per annum plus GST. No leave entitlements or notice period required.
Name: Tony Toohey
Title: Non-Executive Director
Agreement commenced: 31 Octo
Share your feedback
Discover